Driehaus Capital Management LLC Bio Xcel Therapeutics, Inc. Transaction History

Driehaus Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$6.39 - $28.58 $2.34 Million - $10.5 Million	-366,545 Reduced 94.28%	22,220 $147,000
Q1 2023 May 15, 2023	SELL	$17.7 - $33.24 $2.07 Million - $3.89 Million	-117,169 Reduced 23.16%	388,765 $7.25 Million
Q4 2022 Feb 14, 2023	BUY	$10.25 - $22.43 $5.19 Million - $11.3 Million	505,934 New	505,934 $10.9 Million
Q4 2020 Feb 16, 2021	SELL	$42.46 - $56.58 $509,520 - $678,960	-12,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$37.44 - $64.63 $10.2 Million - $17.5 Million	-271,264 Reduced 95.76%	12,000 $520,000
Q2 2020 Aug 14, 2020	SELL	$17.62 - $58.71 $293,690 - $978,578	-16,668 Reduced 5.56%	283,264 $15 Million
Q1 2020 May 15, 2020	BUY	$12.26 - $41.14 $3.68 Million - $12.3 Million	299,932 New	299,932 $6.7 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.81M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.